Cargando…
Histidine supplementation can escalate or rescue HARS deficiency in a Charcot–Marie–Tooth disease model
Aminoacyl-tRNA synthetases are essential enzymes responsible for charging amino acids onto cognate tRNAs during protein synthesis. In histidyl-tRNA synthetase (HARS), autosomal dominant mutations V133F, V155G, Y330C and S356N in the HARS catalytic domain cause Charcot–Marie–Tooth disease type 2 W (C...
Autores principales: | Qiu, Yi, Kenana, Rosan, Beharry, Aruun, Wilhelm, Sarah D P, Hsu, Sung Yuan, Siu, Victoria M, Duennwald, Martin, Heinemann, Ilka U |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941834/ https://www.ncbi.nlm.nih.gov/pubmed/36164730 http://dx.doi.org/10.1093/hmg/ddac239 |
Ejemplares similares
-
Towards a Cure for HARS Disease
por: Wilhelm, Sarah D. P., et al.
Publicado: (2023) -
SIRT2‐knockdown rescues GARS‐induced Charcot‐Marie‐Tooth neuropathy
por: Zhao, Yingying, et al.
Publicado: (2021) -
Diagnosis of Charcot-Marie-Tooth Disease
por: Banchs, Isabel, et al.
Publicado: (2009) -
Charcot–Marie–Tooth disease and intracellular traffic
por: Bucci, Cecilia, et al.
Publicado: (2012) -
Noncompaction Cardiomyopathy with Charcot-Marie-Tooth Disease
por: Eltawansy, Sherif Ali, et al.
Publicado: (2015)